期刊文献+

The current role of dendritic cells in the progression and treatment of colorectal cancer

下载PDF
导出
摘要 Colorectal cancer(CRC)is the third most common cancer and the second leading cause of cancer-related deaths worldwide.Dendritic cells(DCs)constitute a heterogeneous group of antigen-presenting cells that are important for initiating and regulating both innate and adaptive immune responses.As a crucial component of the immune system,DCs have a pivotal role in the pathogenesis and clinical treatment of CRC.DCs cross-present tumor-related antigens to activate T cells and trigger an antitumor immune response.However,the antitumor immune function of DCs is impaired and immune tolerance is promoted due to the presence of the tumor microenvironment.This review systematically elucidates the specific characteristics and functions of different DC subsets,as well as the role that DCs play in the immune response and tolerance within the CRC microenvironment.Moreover,how DCs contribute to the progression of CRC and potential therapies to enhance antitumor immunity on the basis of existing data are also discussed,which will provide new perspectives and approaches for immunotherapy in patients with CRC.
出处 《Cancer Biology & Medicine》 SCIE CAS CSCD 2024年第9期769-783,共15页 癌症生物学与医学(英文版)
基金 This study was supported by grants from the National Natural Science Foundation of China(Grant Nos.82222058,82073197,82273142,and 82173256).
  • 相关文献

参考文献4

二级参考文献14

  • 1Xiao-YuanChu Long-BangChen JingZang Jing-HuaWang QunZhang Huai-ChengGeng.Effect of bone marrow-derived monocytes transfected with RNA of mouse colon carcinoma on specific antitumor immunity[J].World Journal of Gastroenterology,2005,11(5):760-763. 被引量:2
  • 2Fran?ois Ghiringhelli,Cedric Menard,Pierre Emmanuel Puig,Sylvain Ladoire,Stephan Roux,Fran?ois Martin,Eric Solary,Axel Le Cesne,Laurence Zitvogel,Bruno Chauffert.Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients[J].Cancer Immunology Immunotherapy.2007(5) 被引量:1
  • 3Tabernero J,Salazar R,Casado E,Martinelli E,Gomez P,Baselga J.Targeted therapy in advanced colon cancer: the role of new therapies[].Annals of Oncology.2004 被引量:1
  • 4Parkin DM,Bray F,Ferlay J,Pisani P.Global cancer statistics, 2002[].CA Cancer J Clin.2005 被引量:1
  • 5Lorenz M,Staib-Sebler E,Hochmuth K,Heinrich S,Gog C,Vetter G,Encke A,Muller HH.Surgical resection of livermetastases of colorectal carcinoma: short and long-term results[].Semin Oncol.2000 被引量:1
  • 6Pardoll D.Does the immune system see tumors as foreign or self-[].Annu Rev Immunol.2003 被引量:1
  • 7Garcia-Lora A,Algarra I,Garrido F.MHC class I antigens, immune surveillance, and tumor immune escape[].J Cell Physiol.2003 被引量:1
  • 8Drake CG,Jaffee E,Pardoll DM.Mechanisms of immune evasion by tumors[].Adv Immunol.2006 被引量:1
  • 9Yu H,Kortylewski M,Pardoll D.Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment[].Nat Rev Immunol.2007 被引量:1
  • 10Munn DH.Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation[].Curr Opin Immunol.2006 被引量:1

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部